141PD Whole body and intracranial efficacy of ceritinib in patients (pts) with crizotinib (CRZ) pretreated, ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM): Results from ASCEND-1 and ASCEND-2 trials

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

11

Issue :

4, Number 4 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs38562269

Full Text :

https://doi.org/10.1016/S1556-0864(16)30251-9